FOCUS-Novartis wins Medicaid approval for new sickle cell drug in key U.S. states
Novartis AG has secured Medicaid
coverage for a pricey new sickle cell disease therapy in two
U.S. states just weeks after winning U.S. approval, following an
early campaign to convince local officials of its value,
according to a company executive and a Reuters review of public
filings.
coverage for a pricey new sickle cell disease therapy in two
U.S. states just weeks after winning U.S. approval, following an
early campaign to convince local officials of its value,
according to a company executive and a Reuters review of public
filings.
Posted by Reuters
